Want to see ATTO full AI Analyst Report?

Attovia Therapeutics, Inc. (ATTO) Ratios

12 Followers

Attovia Therapeutics, Inc. Ratios

ATTO's free cash flow for Q2 2026 was $0.45. For the 2026 fiscal year, ATTO's free cash flow was decreased by $ and operating cash flow was $-48.45. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 21	Dec 20
Liquidity Ratios
Current Ratio	9.39	14.20	9.39	―	―
Quick Ratio	9.39	14.20	9.39	―	―
Cash Ratio	2.60	3.65	3.97	―	―
Solvency Ratio	-2.49	-3.96	-2.71	―	―
Operating Cash Flow Ratio	-2.77	-5.38	-4.54	―	―
Short-Term Operating Cash Flow Coverage	-17.14	-30.82	0.00	―	―
Net Current Asset Value	$ 102.82M	$ 141.19M	$ 57.89M	$ ―	$ ―
Leverage Ratios
Debt-to-Assets Ratio	0.03	0.03	0.00	―	―
Debt-to-Equity Ratio	0.04	0.03	0.00	―	―
Debt-to-Capital Ratio	0.04	0.03	0.00	―	―
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	―	―
Financial Leverage Ratio	1.14	1.10	1.23	―	―
Debt Service Coverage Ratio	-20.25	-34.54	0.00	―	―
Interest Coverage Ratio	0.00	0.00	0.00	―	―
Debt to Market Cap	<0.01	<0.01	0.00	―	―
Interest Debt Per Share	0.09	0.12	0.00	―	―
Net Debt to EBITDA	0.69	0.53	0.74	―	―
Profitability Margins
Gross Profit Margin	-8.44%	40.44%	0.00%	―	―
EBIT Margin	-9279.56%	-4974.74%	0.00%	―	―
EBITDA Margin	-9171.11%	-4915.19%	0.00%	―	―
Operating Profit Margin	-9279.56%	-4974.74%	0.00%	―	―
Pretax Profit Margin	-8742.89%	-4490.89%	0.00%	―	―
Net Profit Margin	-8742.89%	-4490.89%	0.00%	―	―
Continuous Operations Profit Margin	-8742.89%	-4490.89%	0.00%	―	―
Net Income Per EBT	100.00%	100.00%	100.00%	―	―
EBT Per EBIT	94.22%	90.27%	95.78%	―	―
Return on Assets (ROA)	-30.65%	-36.55%	-51.88%	―	―
Return on Equity (ROE)	-32.05%	-40.21%	-64.06%	―	―
Return on Capital Employed (ROCE)	-36.08%	-43.36%	-60.23%	―	―
Return on Invested Capital (ROIC)	-35.46%	-42.83%	-60.23%	―	―
Return on Tangible Assets	-30.65%	-36.55%	-51.88%	―	―
Earnings Yield	-4.74%	-6.43%	-4.22%	―	―
Efficiency Ratios
Receivables Turnover	0.00	0.00	0.00	―	―
Payables Turnover	0.08	0.23	0.08	―	―
Inventory Turnover	0.00	0.00	0.00	―	―
Fixed Asset Turnover	0.07	0.17	0.00	―	―
Asset Turnover	<0.01	<0.01	0.00	―	―
Working Capital Turnover Ratio	<0.01	0.01	0.00	―	―
Cash Conversion Cycle	-4.49K	-1.61K	-4.83K	―	―
Days of Sales Outstanding	0.00	0.00	0.00	―	―
Days of Inventory Outstanding	0.00	0.00	0.00	―	―
Days of Payables Outstanding	4.49K	1.61K	4.83K	―	―
Operating Cycle	0.00	0.00	0.00	―	―
Cash Flow Ratios
Operating Cash Flow Per Share	-0.77	-1.38	-0.81	―	―
Free Cash Flow Per Share	-0.77	-1.43	-0.86	―	―
CapEx Per Share	<0.01	0.05	0.04	―	―
Free Cash Flow to Operating Cash Flow	1.01	1.04	1.05	―	―
Dividend Paid and CapEx Coverage Ratio	-96.76	-25.59	-19.77	―	―
Capital Expenditure Coverage Ratio	-96.76	-25.59	-19.77	―	―
Operating Cash Flow Coverage Ratio	-8.07	-11.25	0.00	―	―
Operating Cash Flow to Sales Ratio	-77.63	-43.85	0.00	―	―
Free Cash Flow Yield	-4.51%	-6.53%	-3.91%	―	―
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-19.54	-15.42	-20.86	―	―
Price-to-Sales (P/S) Ratio	1.74K	698.03	0.00	―	―
Price-to-Book (P/B) Ratio	7.36	6.25	15.17	―	―
Price-to-Free Cash Flow (P/FCF) Ratio	-22.15	-15.32	-25.60	―	―
Price-to-Operating Cash Flow Ratio	-23.75	-15.92	-26.90	―	―
Price-to-Earnings Growth (PEG) Ratio	0.24	-0.44	0.00	―	―
Price-to-Fair Value	7.36	6.25	15.17	―	―
Enterprise Value Multiple	-18.25	-13.67	-22.11	―	―
Enterprise Value	753.35M	907.40M	911.70M	―	―
EV to EBITDA	-18.25	-13.67	-22.11	―	―
EV to Sales	1.67K	672.15	0.00	―	―
EV to Free Cash Flow	-21.35	-14.75	-24.77	―	―
EV to Operating Cash Flow	-21.57	-15.33	-26.02	―	―
Tangible Book Value Per Share	2.47	3.50	1.44	―	―
Shareholders’ Equity Per Share	2.47	3.50	1.44	―	―
Tax and Other Ratios
Effective Tax Rate	0.00	0.00	0.00	―	―
Revenue Per Share	<0.01	0.03	0.00	―	―
Net Income Per Share	-0.86	-1.41	-0.92	―	―
Tax Burden	1.00	1.00	1.00	―	―
Interest Burden	0.94	0.90	0.96	―	―
Research & Development to Revenue	79.32	40.11	0.00	―	―
SG&A to Revenue	13.40	10.04	0.00	―	―
Stock-Based Compensation to Revenue	0.00	0.00	0.00	―	―
Income Quality	0.89	0.97	0.78	―	―

Currency in USD